Thursday, August 8, 2013

FDA Approves Khedezla for Major Depressive Disorder

We know that, Desvenlafaxine (brand namePristiq), also known as O-desmethylvenlafaxine, is an antidepressant of the serotonin-norepinephrine reuptake inhibitor class developed and marketed by Wyeth (now part of Pfizer). Desvenlafaxine is a synthetic form of the major active metabolite of venlafaxine (sold under the brand names Effexor and Efexor). It is being targeted as the first non-hormonal based treatment for menopause


No comments:

Post a Comment